AJP - Renal Physiology, Vol 270, Issue 2 289-F294, Copyright © 1996 by American Physiological Society

ARTICLES

Amylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin

P. J. Wookey, C. Tikellis, H. C. Du, H. F. Qin, P. M. Sexton and M. E. Cooper
Department of Medicine, University of Melbourne, Victoria, Australia.

125I-labeled rat amylin binds to specific sites in the cortex of rat kidney, which can be distinguished from those for 125I-labeled salmon calcitonin (sCT) and 125I-labeled rat alpha-calcitonin gene-related peptide (alpha-CGRP) on the basis of regional distribution. These sites have a high affinity (approximately 1 nM) for amylin, and 125I-amylin binding is potently inhibited by the peptide antagonists AC413 and sCT-(8-32), whereas CGRP-(8-37) is a poor inhibitor of binding. Furthermore, incubation with guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) inhibits 125I-amylin binding by > 90%, indicating that binding is dependent on coupling to G proteins. In renal cortex, amylin stimulated adenylyl cyclase activity three- to fourfold, and this was inhibited by AC413 and sCT-(8-32) but not by CGRP-(8-37). Amylin activated plasma renin twofold, and this was blunted by prior administration of AC413 but not CGRP-(8-37). We speculate that amylin may play an important role in renal physiology and that in states of hyperamylinemia, as found in obesity and the insulin resistance syndrome, this peptide may be involved in the genesis and development of hypertension.

This article has been cited by other articles:

				N. Tilakaratne, G. Christopoulos, E. T. Zumpe, S. M. Foord, and P. M. Sexton Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 61 - 72. [Abstract] [Full Text]

				R. E. Gilbert, L. L. Wu, D. J. Kelly, A. Cox, J. L. Wilkinson-Berka, C. I. Johnston, and M. E. Cooper Pathological Expression of Renin and Angiotensin II in the Renal Tubule after Subtotal Nephrectomy : Implications for the Pathogenesis of Tubulointerstitial Fibrosis Am. J. Pathol., August 1, 1999; 155(2): 429 - 440. [Abstract] [Full Text] [PDF]

				G. Christopoulos, K. J. Perry, M. Morfis, N. Tilakaratne, Y. Gao, N. J. Fraser, M. J. Main, S. M. Foord, and P. M. Sexton Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product Mol. Pharmacol., July 1, 1999; 56(1): 235 - 242. [Abstract] [Full Text]

				T. Riediger, M. Rauch, and H. A. Schmid Actions of amylin on subfornical organ neurons and on drinking behavior in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R514 - R521. [Abstract] [Full Text] [PDF]

				S. Y. Chai, G. Christopoulos, M. E. Cooper, and P. M. Sexton Characterization of binding sites for amylin, calcitonin, and CGRP in primate kidney Am J Physiol Renal Physiol, January 1, 1998; 274(1): F51 - F62. [Abstract] [Full Text] [PDF]